Orion Group Financial Statement documents 2018 and Corporate Governance Statement published

NEXT STORY
Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency
PREV STORY
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2018 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Surface Oncology Presents Promising Preclinical Data for Lead Immunotherapy Product Candidates at the American Association for Cancer Research Annual Meeting

author_avatar
NASDAQ Market News

Worldwide Rat and Mouse Model Industry to 2028 – Utility of Rat/Mouse Models to Examine the Pathogenesis of SARS-CoV-2 Presents Opportunities

author_avatar
NASDAQ Market News

Adaptive Biotechnologies to Present at the 40th Annual Cowen Health Care Conference

author_avatar
NASDAQ Market News